Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension
Sponsor: University of California, San Francisco
This observational or N/A phase trial investigates Endothelial Function and HIV Infection and is currently completed. University of California, San Francisco leads this study, which shows 14 recorded versions since 2007 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jan 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting
▶ Show 9 earlier versions
-
Nov 2020 — Dec 2020 [monthly]
Active Not Recruiting
-
Jul 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
Oct 2019 — Jul 2020 [monthly]
Active Not Recruiting
-
Jan 2019 — Oct 2019 [monthly]
Active Not Recruiting
-
Jun 2018 — Jan 2019 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
First recorded
Nov 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .